Domestic Delivery and same-day shipping.
USA Domestic Delivery and Same-Day Shipping
USA Domestic Delivery and Same-Day Shipping
USA Domestic Delivery and Same-Day Shipping
USA Domestic Delivery and Same-Day Shipping
USA Domestic Delivery and Same-Day Shipping
USA Domestic Delivery and Same-Day Shipping

Delta Sleep Inducing Peptide, or DSIP, is a small protein. Scientists first found it in the brains of rats during deep sleep in 1977. They named it for its ability to promote delta or slow-wave sleep. Since then, DSIP has gained attention as a possible peptide for sleep, stress control, pain relief, and even cancer prevention.

This sleep-inducing peptide may help the body in many ways, but it’s still being studied.

How DSIP Helps With Sleep

DSIP got its name because of how it helped rabbits fall asleep. But how it works in people is still not 100% clear. Some studies show that DSIP peptide for sleep helps people fall asleep faster. In other studies, it didn’t show much effect at all.

In one study, DSIP caused alertness during the first hour of sleep and then made the subjects feel sleepy in the second hour. Other research shows that DSIP may help balance the sleep cycle. It supports natural, deep sleep and reduces sleep problems over time.

Many people with chronic insomnia responded well to DSIP. They fell asleep faster and stayed asleep longer. Some even had sleep patterns that were as good as people without sleep problems. These results show that the sleep peptide might help fix broken sleep cycles.

Although EEG tests (used to track brain waves) didn’t always show big changes, people reported sleeping better and feeling more rested. This suggests that current testing methods might not fully show DSIP’s true effect on natural sleep.

DSIP might not be a strong sedative like sleeping pills. Instead, it could support the body’s natural ability to fall and stay asleep. That’s why many researchers now believe that peptides for sleep like DSIP are worth more study.

DSIP Dosing and Use

There is no official DSIP peptide dosing guide yet. Research studies often use small doses and increase slowly over time. Many users report improvements in sleep after a few days of use. However, more testing is needed to find the best and safest way to use this sleep peptide.

As always, DSIP is for research use only and is not approved for human use outside clinical trials.

DSIP and Pain Relief

Chronic pain is hard to treat. Drugs like opioids or NSAIDs (pain relievers) often come with serious side effects. Some people build a tolerance or even become addicted. That’s why scientists are exploring DSIP.

In one study, DSIP helped reduce pain and improve mood. It even helped people coming off pain meds. They had fewer withdrawal symptoms and less pain rebound.

Animal studies showed that DSIP worked on brain receptors tied to pain relief. These are some of the same receptors that opioids target—but DSIP didn’t cause addiction. This makes it a very promising option for long-term pain control.

DSIP and Stress

DSIP also plays a role in how the body handles stress. Under stress, our cells switch from using oxygen (which is efficient) to a method that works without oxygen (which creates more waste and damage). This switch can hurt the body, especially the brain and heart.

In rat studies, DSIP helped the body keep using oxygen. This protected the cells from damage, even during low oxygen conditions. These findings suggest DSIP might help during strokes, heart attacks, or other health issues that block blood flow.

By helping the body avoid harmful metabolic changes, DSIP may act as a strong antioxidant. It protects the body at a very deep cellular level. This might make it useful in anti-aging treatments.

DSIP and Mental Health

Sleep problems and depression often go hand in hand. So, it’s no surprise that researchers are studying DSIP for mental health.

One study found that people with major depression had lower levels of DSIP in their spinal fluid. DSIP also affects chemicals like serotonin and monoamine oxidase (MAO-A), both of which are involved in mood regulation.

Even though no treatments directly target DSIP for depression yet, the link is strong. DSIP may also affect the hypothalamic-pituitary-adrenal (HPA) axis, a part of the body tied to mood and stress. Some researchers believe it could help reduce suicidal thoughts by calming this system.

DSIP for Addiction and Withdrawal

Withdrawal from alcohol or opioids can be painful and dangerous. DSIP might make this process easier.

In a study of 107 people detoxing from alcohol or opioids, DSIP helped most of them. Nearly all saw relief from withdrawal symptoms. Alcohol withdrawal responded best, but opioid withdrawal needed more doses over a longer time.

Even so, the results are hopeful. If DSIP can safely ease withdrawal, it could be a big step forward in addiction treatment.

DSIP and Cancer Prevention

Most cancer research focuses on treatment after cancer appears. But DSIP may help stop cancer before it starts.

In one long-term study, female mice got DSIP injections for five days each month, starting at three months old. These mice had far fewer tumours than untreated mice—about 2.6 times fewer. They also had fewer genetic defects in their bone marrow.

This shows that DSIP peptide for sleep may help the body prevent cancer at a genetic level. It doesn’t just treat disease—it might help stop it from ever taking hold.

DSIP and Chemotherapy Side Effects

Chemo can damage the brain, especially in children. Problems with movement, behaviour, and speech are common. DSIP may help here, too.

In animal studies, DSIP and its alternative, Deltaran, increased brain blood flow. This helped protect against damage caused by chemo or strokes. In fact, rats treated with Deltaran had a 100% survival rate in one test—compared to just 62% in untreated rats.

By boosting blood flow, DSIP helps the brain heal and function better under stress. This could be a big benefit for cancer patients.

Other Possible Benefits of DSIP

DSIP is found in both the brain and the rest of the body. This suggests it may do more than help you sleep. DSIP might act like a hormone that helps control many body functions.

For example, DSIP seems to stop the release of a hormone that limits muscle growth. This could help muscles grow bigger and stronger. It may also regulate body temperature, heart rate, blood pressure, and immune responses.

All these changes often happen before sleep. DSIP may prepare the body for sleep by balancing these systems. That would make it more of a “sleep manager” than a sedative.

DSIP Structure and Formula

  • Sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
  • CAS Number: 62568-57-4
  • Molecular Formula: C35H48N10O15
  • Molecular Weight: 848.824 g/mol

Final Thoughts: Is DSIP a Real Sleep Solution?

Delta sleep-inducing peptide is a promising compound. It may not work the same way as traditional sleeping pills, but it could help the body fix its sleep cycle. DSIP might support deep sleep, improve mood, ease pain, reduce stress, and even prevent disease.

While DSIP peptide dosing is still being researched, early results are promising. This peptide for sleep could one day be a key tool in treating insomnia, anxiety, addiction, and more. It’s still early, but DSIP is a strong candidate in the world of peptides for sleep and health support.

As research continues, DSIP may become one of the most valuable tools in natural sleep science and wellness.

Referenced Citations

  1. “The influence of synthetic DSIP (delta-sleep-inducing-peptide) on disturbed human sleep | SpringerLink.” [Online]. Available: https://link.springer.com/article/10.1007%2FBF01971753. [Accessed: 25-Jun-2019].
  2. “Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia. – PubMed – NCBI.” [Online]. Available: https://www.ncbi.nlm.nih.gov/pubmed/3622582. [Accessed: 25-Jun-2019].
  3. “Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study. – PubMed – NCBI.” [Online]. Available: https://www.ncbi.nlm.nih.gov/pubmed/1299794. [Accessed: 25-Jun-2019].
  4. “Acute and delayed effects of DSIP (delta sleep-inducing peptide) on human sleep behavior. – PubMed – NCBI.” [Online]. Available: https://www.ncbi.nlm.nih.gov/pubmed/6895513. [Accessed: 25-Jun-2019].
  5. “Therapeutic effects of delta-sleep-inducing peptide (DSIP) in patients with chronic, pronounced pain episodes. A clinical pilot study. – PubMed – NCBI.” [Online]. Available: https://www.ncbi.nlm.nih.gov/pubmed/6548970. [Accessed: 25-Jun-2019].
  6. “Potent antinociceptive effect of centrally administered delta-sleep-inducing peptide (DSIP). – PubMed – NCBI.” [Online]. Available: https://www.ncbi.nlm.nih.gov/pubmed/2853064. [Accessed: 25-Jun-2019].
  7. “Delta sleep inducing peptide (DSIP): effect on respiration activity in rat brain mitochondria and stress protective potency under experimental hypo… – PubMed – NCBI.” [Online]. Available: https://www.ncbi.nlm.nih.gov/pubmed/12668217. [Accessed: 25-Jun-2019].
  8. “Effects of delta-sleep inducing peptide (DSIP) and some analogues on the activity of monoamine oxidase type A in rat brain under hypoxia stress. – PubMed – NCBI.” [Online]. Available: https://www.ncbi.nlm.nih.gov/pubmed/7628639. [Accessed: 25-Jun-2019].
  9. “Decreased concentrations of delta-sleep inducing peptide in plasma and cerebrospinal fluid from depressed patients: Nordisk Psykiatrisk Tidsskrift: Vol 39, No sup11.” [Online]. Available: https://www.tandfonline.com/doi/abs/10.3109/08039488509101959. [Accessed: 25-Jun-2019].
  10. “Delta sleep-inducing peptide (DSIP): An overview of central actions and possible relationship to psychiatric illnesses: Nordisk Psykiatrisk Tidsskrift: Vol 42, No 2.” [Online]. Available: https://www.tandfonline.com/doi/abs/10.3109/08039488809103215. [Accessed: 25-Jun-2019].
  11. “High delta sleep-inducing peptide-like immunoreactivity in plasma in suicidal patients with major depressive disorder. – PubMed – NCBI.” [Online]. Available: https://www.ncbi.nlm.nih.gov/pubmed/9606527. [Accessed: 25-Jun-2019].
  12. “Opioid detoxification with delta sleep-inducing peptide: results of an open clinical trial. – PubMed – NCBI.” [Online]. Available: https://www.ncbi.nlm.nih.gov/pubmed/9617990. [Accessed: 25-Jun-2019].
  13. “DSIP in the treatment of withdrawal syndromes from alcohol and opiates. – PubMed – NCBI.” [Online]. Available: https://www.ncbi.nlm.nih.gov/pubmed/6548969. [Accessed: 25-Jun-2019].
  14. “Effect of delta-sleep inducing peptide-containing preparation Deltaran on biomarkers of aging, life span and spontaneous tumor incidence in female … – PubMed – NCBI.” [Online]. Available: https://www.ncbi.nlm.nih.gov/pubmed/12782416. [Accessed: 25-Jun-2019].
  15. A. B. Sinyukhin, G. P. Timoshinov, V. A. Kornilov, and P. D. Shabanov, “P.7.a.006 Delta sleep-inducing peptide analogue corrects the CNS functional state of children treated with antiblastomic therapy,” Eur. Neuropsychopharmacol., vol. 19, pp. S681–S682, Sep. 2009.
  16. E. V. Koplik et al., “Delta sleep-inducing peptide and Deltaran: potential approaches to antistress protection,” Neurosci. Behav. Physiol., vol. 38, no. 9, pp. 953–957, Nov. 2008.
  17. “[DSIP: the sleep peptide or an unknown hypothalamic hormone?]. – PubMed – NCBI.” [Online]. Available: https://www.ncbi.nlm.nih.gov/pubmed/7817664. [Accessed: 25-Jun-2019].
  18. “DSIP–a tool for investigating the sleep onset mechanism: a review. – PubMed – NCBI.” [Online]. Available: https://www.ncbi.nlm.nih.gov/pubmed/3286557. [Accessed: 25-Jun-2019].
  19.  Shlomo Yehuda & Ralph L. Carasso (1987) The Effects of Dsip on Pain Threshold During Light and Dark Periods in Rats are not Naloxone-Sensitive, International Journal of Neuroscience, 37:1-2, 85-88, DOI: 10.3109/00207458708991805
  20.  Graf, Markus & Christen, Heinz & Schoenenberger, Guido. (1982). DSIP/DSIP-P and circadian motor activity of rats under continuous light. Peptides. 3. 623-6. 10.1016/0196-9781(82)90161-9.
  21.  Shlomo Yehuda & Ralph L. Carasso (1988) Dsip-a Tool for Investigating the Sleep Onset Mechanism: A Review, International Journal of Neuroscience, 38:3-4, 345-353, DOI: 10.3109/00207458808990695
  22.  Yehuda, S., Kastin, A.J. and Coy, D.H. (1980). Thermoregulatory and locomotor effects of DSIP: Paradoxical interaction with d-amphetamine. Pharmacology Biochemistry and Behavior, [online] 13(6), pp.895–900. Available at: https://www.sciencedirect.com/science/article/pii/0091305780902257